3-deoxyglucosone has been researched along with epalrestat in 2 studies
| Studies (3-deoxyglucosone) | Trials (3-deoxyglucosone) | Recent Studies (post-2010) (3-deoxyglucosone) | Studies (epalrestat) | Trials (epalrestat) | Recent Studies (post-2010) (epalrestat) |
|---|---|---|---|---|---|
| 186 | 8 | 77 | 243 | 22 | 100 |
| Protein | Taxonomy | 3-deoxyglucosone (IC50) | epalrestat (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 7.9635 | |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 6.5 | |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 0.1836 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.5596 | |
| Aldo-keto reductase family 1 member A1 | Homo sapiens (human) | 2.6 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.1335 | |
| Aldo-keto reductase family 1 member B1 | Bos taurus (cattle) | 0.17 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.085 | |
| Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | 1.5 | |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | 1.5 | |
| Aldo-keto reductase family 1 member B7 | Rattus norvegicus (Norway rat) | 1.198 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, N; Hamada, Y; Horiuchi, S; Hotta, N | 1 |
| Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
2 other study(ies) available for 3-deoxyglucosone and epalrestat
| Article | Year |
|---|---|
Role of polyol pathway in nonenzymatic glycation.
Topics: Aldehyde Reductase; Animals; Cattle; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Erythrocytes; Fructosephosphates; Glycation End Products, Advanced; Glycosylation; Humans; In Vitro Techniques; Polymers; Rhodanine; Serum Albumin, Bovine; Thiazolidines | 1996 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |